Event Report 2025
-
APAC Project
Visit to 3 Southeast Asian countries for the 15th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations)
- Mission: Enhancing access to innovative medicines for the people in Asia - - The "Kusurium", a permanent exhibition
～Mission: Enhancing access to innovative medicines for the people in Asia - -
Public Relations Committee
The 44th Public Relations Seminar
～The 44th Public Relations Seminar - Message Writing and Diction -
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
Secretariat
BioJapan2025 Luncheon Seminar "Meeting the Challenges of Access to Medicines: Co-creation between the Public and Private Sectors
-
Biopharmaceutical Committee
Report on BioJapan 2025
Opening Ceremony, Keynote Speech and Biopharmaceutical Seminar -
International Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
～The 11th Nikkei-FT Conference on Infectious Diseases held -
International Committee
Report on Side Events Held during the UN General Assembly
Global expansion of NCDs control through Japan-originated innovation and multi-stakeholder partnerships: Pathways to realization of UHC -
Code Compliance Promotion Committee
Held the "2025 Meeting of Code Administration Managers and Practitioners
-
Quality Committee
Holding of "The 52nd GMP Case Study Workshop in FY 2025
Strengthening Quality Assurance Implementation Capability and Site-Driven Problem Solving Approach -
Regulatory Affairs Committee
The 15th Annual Conference of the Regulatory Science Society of Japan to be held
Quality Assurance and Regulatory Science -
Biopharmaceutical Committee
The "Pharmaceutical Consortium of Japan Media Forum" (Part 2)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Committee
The "Pharmaceutical Manufacturers' Association of Japan (PMAJ) Media Forum" (Part 1)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Committee
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
Secretariat
Held the first "Co-creation Meeting" of the Pharmaceutical Manufacturers Association of Japan (PMAJ)!
Committee Chairs, Executives, and Secretariat Meet to Discuss the Realization of Industrial Vision 2035 -
International Committee
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industries from Japan and Korea gathered to discuss common issues -
International Committee
Strengthening Strategic Partnerships to Combat Infectious Diseases (Vector-Borne Diseases, Neglected Tropical Diseases, Emerging Infectious Diseases)" at the WHA78 side event in Geneva
Japan's Contributions and Strategic Partnerships in the Fight against Infectious Diseases -
Industry Policy Committee
Pharmaceutical Association of Japan members participate in the DIA 2025 Global Annual Meeting
Communicating to the world about efforts to tackle the drug lag and loss problem -
Public Relations Committee
The 43rd Public Relations Seminar" was held.
～The 44th Public Relations Seminar - Message Writing and Diction -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Asuka Miyabashira, new president of the Pharmaceutical Manufacturers Association of Japan (PMAJ), delivers her policy statement -
Secretariat
President Kinoshita of the Pharmaceutical Manufacturers Association of Japan (PAPJ) speaks at a panel organized by "Endpoints News" in the U.S.
-
Secretariat
Dr. Ishida, Executive Director of the Pharmaceutical Manufacturers Association of Japan (PAPJ), speaks at an online event for students
-
APAC Project
The 14th APAC (Asian Association of Pharmaceutical Manufacturers and Associations) Conference was held.
Mission: Rapidly bring innovative medicines to the people of Asia -
Regulatory Affairs Committee
Joint General Meeting of the Drug Evaluation Committee and Pharmaceutical Affairs Committee for FY 2025
-
International Committee
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
Product Information Summary Review Meeting
Held the "FY2024 Workshop for Persons Responsible for Product Information Outline Management and Practice Managers
-
Public Relations Committee
Held a hands-on event "Pharmaceutical Cooperative Association of Japan Kusurium Laboratory
Three new exhibits are also on display in the permanent exhibition "Drugs Room - Cusrium". -
Code Compliance Promotion Committee
Held the "FY2024 Meeting for Persons Responsible for Compliance Management and Practitioners".
-
Public Relations Committee
The 36th Pharmaceutical Association of Japan (PAK) Policy Seminar held
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society -
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Diverse Values of Pharmaceuticals "What are the diverse values brought by new modalities - Case study of SMA (Spinal Muscular Atrophy) -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
The Pharmaceutical Manufacturers Association of Japan (PALMA) publishes Industry Vision 2035 and PALMA Policy Proposal 2025 -
Industry Policy Committee
Report on the "Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
Symposium co-hosted by the Pharmaceutical Manufacturers Association of Japan (PMAJ) and RDD Japan Secretariat -
Industry Policy Committee
Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
-
Intellectual Property Committee
2025 Life Science Intellectual Property Forum" was held by the Japan Pharmaceutical Manufacturers Association (JPMA).
Intellectual Property Work at a Turning Point - What is Required of the Personnel Who Handle It -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
International Committee
The 2nd Neglected Tropical Diseases Contest" was held.